The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Blackstone Executive Vice Chairman Tony James says he's less optimistic now than before that the U.S.-China trade war could be resolved, but even a smaller deal could help...World Economyread more
Progress on trade talks will determine how far market will move above new highs.Trader Talk with Bob Pisaniread more
Check out the companies making headlines before the bell:
Celgene agreed to sell the rights to its Otezla psoriasis drug to Amgen for $13.4 billion in cash. Bristol-Myers Squibb had previously agreed to the Otezla divestiture to win approval for its pending merger with Celgene.
Tesla is planning to raise prices in China this week according to a Reuters report. That would be earlier than originally planned. The electric automaker is said to be considering another increase in December if Chinese tariffs on U.S.-made cars take effect.
Walt Disney will launch stores inside 25 Target locations in October, and plans to launch 40 more of the "stores within a store" by October 2020. The first locations will be in major cities including Philadelphia, Denver, and Chicago.
Drugmaker Mallinckrodt is under scrutiny for its role in the opioid crisis, according to a Wall Street Journal report. The paper notes that the bulk of the attention surrounding opioids has focused on OxyContin maker Purdue Pharma, but that other drug makers like Mallinckrodt are drawing more focus as more legal documents become public.
Defense contractor Raytheon won a $534 million Army contract for infrared viewers used by military tanks to select targets.
3M shares are not at bargain levels despite a 16% year-to-date drop in the shares, according to an article in Barron's. The paper said potential environmental liabilities threaten to erode 3M's valuation further.
Cree was downgraded to "underweight" from "neutral" at Piper Jaffray, following the lighting products maker's last quarterly results and weaker than expected outlook. The firm also cut its price target for the stock to $38 per share from $57.
Dish Network was upgraded to "strong buy" from "market perform" at Raymond James, which sees upside for the satellite TV operator on multiple fronts involving both its pay-TV and wireless operations.
Foot Locker – Susquehanna Financial downgraded the athletic footwear and apparel retailer's stock to "neutral" from "positive", noting disappointing second quarter results and saying that Foot Locker's outlook is still too optimistic.
Lyft – The ride-hailing service's stock was upgraded to "buy" from "neutral" at Guggenheim Securities, citing several factors including rising fares.